The purpose of this study is to preliminarily determine whether the frequency and/or severity
of vasomotor symptoms (VMS) at baseline, and then after symptom reduction with gabapentin,
relates to various cardiovascular control measures.
Phase:
N/A
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
Brigham and Women's Hospital Spaulding Rehabilitation Hospital